Clinical Trial Update: Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on eribulin in combination with anlotinib for HER2-negative locally advanced or metastatic breast cancer; current status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Eribulin (eribulin mesilate)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN